Quantum-Si Incorporated (NASDAQ: QSI) on Tuesday, plunged -6.30% from the previous trading day, before settling in for the closing price of $1.27. Within the past 52 weeks, QSI’s price has moved between $0.95 and $3.10.
During the last 5-year period, the sales growth of Healthcare Sector giant was 33.79%. The company achieved an average annual earnings per share of 25.29%. With a float of $172.03 million, this company’s outstanding shares have now reached $195.52 million.
Quantum-Si Incorporated (QSI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Quantum-Si Incorporated is 20.17%, while institutional ownership is 27.11%. The most recent insider transaction that took place on Dec 22 ’25, was worth 27,979. In this transaction Chief Product Officer of this company sold 21,927 shares at a rate of $1.28, taking the stock ownership to the 800,973 shares. Before that another transaction happened on Dec 22 ’25, when Company’s Officer proposed sale 21,927 for $1.28, making the entire transaction worth $27,979.
Quantum-Si Incorporated (QSI) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.16 earnings per share (EPS) for the period topping the consensus outlook (set at -0.19) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.81% during the next five years compared to 33.79% growth over the previous five years of trading.
Quantum-Si Incorporated (NASDAQ: QSI) Trading Performance Indicators
Quantum-Si Incorporated (QSI) is currently performing well based on its current performance indicators. A quick ratio of 10.59 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 80.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.45 in one year’s time.
